粘膜殖民工程1917年用于向肠道输送和恢复微生物群在炎症性肠道疾病中的恒温
Hemin Wang1,2,3, Qing Li1,2,3, Xianan Zhang1,2,3
1School of Public Health, Capital Medical University, Beijing, P. R. China.
Small (Weinheim an der Bergstrasse, Germany)
|December 29, 2025
概括
具有向肠道输送的工程益生菌有效地恢复了炎症性肠病 (IBD) 中的微生物群平衡. 这种创新方法提高了IBD患者的治疗持续性和疗效.
科学领域:
- 胃肠病学 胃肠病学
- 微生物学 微生物学
- 生物技术是生物技术.
背景情况:
- 炎症性肠病 (IBD) 是一个日益严重的全球健康挑战.
- 目前用于IBD的口服益生菌治疗在结肠植入和炎症区域内持续活动方面存在局限性.
- 恢复肠道微生物群的稳态对于控制IBD至关重要.
研究的目的:
- 设计一种益生菌 (EcN) 以增强粘膜殖民性和在炎症结肠中提供向的药物.
- 开发一个基于益生菌的平台 (OME),用于协同药物输送和IBD治疗效果.
- 研究OME改善肠道炎症并恢复免疫平衡的机制.
主要方法:
- 改造的尼斯尔1917 (EcN) 与2-伊米诺醇化为增强粘液结合的修改.
- 开发一种益生菌 - 药物结合物 (OME),使用矿化来将奥诺宁载入EcN.
- 在DSS诱导的IBD模型中评估OME的疗效,包括微生物群分析和免疫细胞分析.
主要成果:
- 工程EcN在炎症结肠中改善了保留和活性,恢复了微生物群的恒常性.
- 口服OME成功地殖民了肠道,并将Ononine输送到炎症的结肠中,显示出协同的治疗效果.
- 经过OME治疗,Eubacterium coprostanoligenes的调节升高,调节T细胞反应并恢复免疫常态,改善DSS诱导的炎症.
结论:
- 粘膜殖民工程 EcN 提供了一个有前途的策略,用于向药物输送和恢复IBD中的肠道微生物群平衡.
- OME平台为IBD治疗提供了一种新的协同方法,具有临床转化潜力.
- 这项研究促进了对益生菌工程和针对炎症性肠道疾病的向治疗的理解.
相关概念视频
01:21Inflammatory Bowel Disease V: Surgical Management
423
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
423
01:29Inflammatory Bowel Disease IV: Pharmacological Management
439
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
439